IL83585A0 - Formulations of alpha-interferons and their preparation - Google Patents

Formulations of alpha-interferons and their preparation

Info

Publication number
IL83585A0
IL83585A0 IL83585A IL8358587A IL83585A0 IL 83585 A0 IL83585 A0 IL 83585A0 IL 83585 A IL83585 A IL 83585A IL 8358587 A IL8358587 A IL 8358587A IL 83585 A0 IL83585 A0 IL 83585A0
Authority
IL
Israel
Prior art keywords
interferons
formulations
alpha
preparation
Prior art date
Application number
IL83585A
Other languages
English (en)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL83585A0 publication Critical patent/IL83585A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL83585A 1986-08-21 1987-08-19 Formulations of alpha-interferons and their preparation IL83585A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863628468 DE3628468A1 (de) 1986-08-21 1986-08-21 Neue applikationsformen fuer (alpha)-interferone

Publications (1)

Publication Number Publication Date
IL83585A0 true IL83585A0 (en) 1988-01-31

Family

ID=6307914

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83585A IL83585A0 (en) 1986-08-21 1987-08-19 Formulations of alpha-interferons and their preparation

Country Status (14)

Country Link
US (1) US4824674A (sv)
EP (1) EP0258683A3 (sv)
JP (1) JPS6351338A (sv)
KR (1) KR880002541A (sv)
AU (1) AU590958B2 (sv)
CA (1) CA1313131C (sv)
DE (1) DE3628468A1 (sv)
DK (1) DK434087A (sv)
FI (1) FI89007C (sv)
IL (1) IL83585A0 (sv)
NO (1) NO873513L (sv)
NZ (1) NZ221497A (sv)
PT (1) PT85561B (sv)
ZA (1) ZA876166B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE3826055A1 (de) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh Mit reagenz abloesbar impraegnierte traegermatrix
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
JPH07501320A (ja) * 1991-10-11 1995-02-09 ギリーズ,マーク・セドリック インタ−フェロン・アルファによる眼線維症の治療
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
DE19549506C2 (de) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
CA2335636A1 (en) * 1998-06-22 1999-12-29 Unihart Corporation Sticking plaster for controlled release of natural interferon
US20030206945A1 (en) * 2000-12-20 2003-11-06 Giulio Tarro Sticking plaster for controlled release of natural interferon
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
AU2002353484A1 (en) 2001-12-04 2003-06-17 Discure Ltd. Cushion bearing implants for load bearing applications
WO2012064627A2 (en) 2010-11-08 2012-05-18 Genentech, Inc. Subcutaneously administered anti-il-6 receptor antibody
EP2996673A1 (en) * 2013-05-16 2016-03-23 Universiteit Antwerpen Thermolabile drug release formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055895A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Interferon purification
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
SE374272B (sv) * 1973-08-31 1975-03-03 D A Safwat
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction
US4363634A (en) * 1980-07-18 1982-12-14 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
JPS5892621A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロンを安定に配合した製剤
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
JPS59181224A (ja) * 1983-03-29 1984-10-15 Sumitomo Chem Co Ltd 安定なインタ−フエロン製剤の製法
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3513288A1 (de) * 1985-04-13 1986-10-23 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren und vorrichtung zur beaufschlagung von augenstaebchen mit wirkstoffloesungen oder -suspensionen

Also Published As

Publication number Publication date
ZA876166B (en) 1989-05-30
KR880002541A (ko) 1988-05-09
DE3628468A1 (de) 1988-03-03
JPS6351338A (ja) 1988-03-04
DK434087D0 (da) 1987-08-20
NO873513D0 (no) 1987-08-20
FI873593A (fi) 1988-02-22
FI873593A0 (fi) 1987-08-20
PT85561B (pt) 1990-05-31
PT85561A (de) 1987-09-01
CA1313131C (en) 1993-01-26
DK434087A (da) 1988-02-22
AU7730787A (en) 1988-02-25
AU590958B2 (en) 1989-11-23
FI89007B (fi) 1993-04-30
EP0258683A2 (de) 1988-03-09
NO873513L (no) 1988-02-22
NZ221497A (en) 1990-04-26
EP0258683A3 (de) 1988-09-07
US4824674A (en) 1989-04-25
FI89007C (sv) 1993-08-10

Similar Documents

Publication Publication Date Title
ZA852864B (en) Preparation of functional human factor viii
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
GR871659B (en) Substituted a-aminoacids their preparation and pharmaceutical compositions containing them
IL83444A0 (en) Sweetmeats and their manufacture
IL83585A0 (en) Formulations of alpha-interferons and their preparation
IL83663A0 (en) Preparation of 3-pyrrolidinols
GR860075B (en) Compositions their preparation and use
GB8629594D0 (en) Preparation of polysilanes
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
DE3760806D1 (en) Monohalogenotrifluorooxetane and its preparation
GB8727401D0 (en) Preparation of trifluoromethylbenzonitrile
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
IL82218A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
NZ218890A (en) Fluorinated diaminoalkyne derivatives and pharmaceutical compositions
IL72862A0 (en) Aminocyclopentanes and their preparation and pharmaceutical formulations
IL81920A0 (en) Vaccines and their preparation
IL82217A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
GB2193206B (en) Preparation of taurine-containing peptides
GB2194235B (en) Dichlorotrifluoromethyltoluenes and preparation thereof
GB2196961B (en) Preparation of polyfluoroenolates
IL84778A0 (en) Preparation of mercaptobenzoates
GB8708603D0 (en) Preparation of()-13-norfaranal
GB8703882D0 (en) Preparation of encainide
IL83517A (en) Preparation of n-cyano-methylarylcarboxamides